Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia.

Abstract	Acute mesenteric ischemia (AMI) is a rare condition that may be associated with a variety of congenital prothrombotic disorders (PDs). The purpose of this study was to assess the prevalence of these disorders in 28 AMI patients compared with 103 healthy individuals from the northeastern region of Turkey. They were screened for protein C, antithrombin III, and protein S deficiencies; and gene analysis was performed using the polymerase chain reaction. A PD was revealed in 16 (57%) patients and 33 (32%) controls (p = 0.020). Factor V Leiden (FVL), prothrombin G20210A mutation, and TT677 homozygous mutation of methylenetetrahydrofolate reductase was detected in 10 (36%) patients versus 16 (15%) controls (p = 0.035), 3 (11%) patients versus 10 (9%) controls (p = 1.00), and 1 (3%) patient versus no controls, respectively. Consistent with caucasian ethnic groups, there was high prevalence of PDs, especially FVL; and these abnormalities might be a significant predisposing factor in the pathogenesis of AMI.
Authors	Nazim Ağaoğlu, Serdar Türkyilmaz, Ercüment Ovali, Fahri Uçar, Celal Ağaoğlu
Journal	World journal of surgery (World J Surg) Vol. 29 Issue 9 Pg. 1135-8 (Sep 2005) ISSN: 0364-2313 [Print] United States
PMID	16086214 (Publication Type: Journal Article)
Chemical References	factor V Leiden Antithrombin III Factor V Methylenetetrahydrofolate Reductase (NADPH2)
Topics	Acute Disease Aged Aged, 80 and over Antithrombin III (metabolism) Blood Coagulation Disorders (diagnosis, epidemiology, genetics) Case-Control Studies Enzyme-Linked Immunosorbent Assay Factor V (genetics) Female Humans Ischemia (epidemiology) Male Mesenteric Veins Methylenetetrahydrofolate Reductase (NADPH2) (genetics) Middle Aged Mutation Polymerase Chain Reaction Prevalence Protein C Deficiency (diagnosis, epidemiology, genetics) Protein S Deficiency (diagnosis, epidemiology, genetics) Thrombosis (diagnosis, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!